awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47687376-4B7FE7E1-EA45-4324-872E-C293690A5E83
Q47687376-4B7FE7E1-EA45-4324-872E-C293690A5E83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47687376-4B7FE7E1-EA45-4324-872E-C293690A5E83
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
P2860
Q47687376-4B7FE7E1-EA45-4324-872E-C293690A5E83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47687376-4B7FE7E1-EA45-4324-872E-C293690A5E83
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b34d3a73cbaa8321c8eb8a03ea5a4c8390ef9133
P2860
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.